AmritaDesaiPAMasters in Clinical Health Services

PubMed

• 43 citations
  In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response
  Sara A. Hurvitz, Ondrej Kalous, Dylan Conklin, Amrita J. Desai, Judy Dering, Lee Anderson, Neil A. O'Brien, Teodora Kolarova, Richard S. Finn, Ronald Linnartz, David C...> ;Breast Cancer Research and Treatment. 2015 Feb 8
• 21 citations
  AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53
  Ondrej Kalous, Dylan Conklin, Amrita J. Desai, Judy Dering, Jennifer Brooke Goldstein, Charles Ginther, Lee Anderson, Ming Lu, Teodora Kolarova, Mark A. Eckardt, Anita...> ;Breast Cancer Research and Treatment. 2013 Oct 5
• 86 citations
  PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentratio...
  Joshua E. Logan, Nikayeh Mostofizadeh, Amrita J. Desai, Erika von Euw, Dylan Conklin, Veerauo Konkankit, Habib Hamidi, Mark A. Eckardt, Lee Anderson, Hsiao-Wang Chen, ...> ;Anticancer Research. 2013 Aug 1
• 54 citations
  Inhibition of HSP90 with AUY922 Induces Synergy in HER2-Amplified Trastuzumab-Resistant Breast and Gastric Cancer
  Zev A. Wainberg, Adrian Anghel, Amy M. Rogers, Amrita J. Desai, Ondrej Kalous, Dylan Conklin, Raul Ayala, Neil A. O'Brien, Cornelia Quadt, Mikhail Akimov, Dennis J. Sl...> ;Molecular Cancer Therapeutics. 2013 Apr 1
• 55 citations
  The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non–Small Cell Lung Cancer Growth
  Edward B. Garon, Richard S. Finn, Habib Hamidi, Judy Dering, Sharon Pitts, Naeimeh Kamranpour, Amrita J. Desai, Wylie Hosmer, Susan Ide, Emin Avsar, Michael Rugaard Je...> ;Molecular Cancer Therapeutics. 2013 Mar 14
• 46 citations
  Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer
  Edward B. Garon, Richard J. Pietras, Richard S. Finn, Naeimeh Kamranpour, Sharon Pitts, Diana C. Márquez-Garbán, Amrita J. Desai, Judy Dering, Wylie Hosmer, Erika von ...> ;Journal of Thoracic Oncology. 2013 Mar 1
• 55 citations
  Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib
  Ondrej Kalous, Dylan Conklin, Amrita J. Desai, Neil A. O'Brien, Charles Ginther, Lee Anderson, David Cohen, Carolyn D. Britten, Ian Taylor, James G. Christensen, Denni...> ;Molecular Cancer Therapeutics. 2012 Sep 1
• 48 citations
  Identification of Common Predictive Markers of In vitro Response to the Mek Inhibitor Selumetinib (AZD6244; ARRY-142886) in Human Breast Cancer and Non–Small Cell Lung...
  Edward B. Garon, Richard S. Finn, Wylie Hosmer, Judy Dering, Charles Ginther, Shahriar Adhami, Naeimeh Kamranpour, Sharon Pitts, Amrita Desai, David Elashoff, Tim Fren...> ;Molecular Cancer Therapeutics. 2010 Jul 1
• 166 citations
  Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo.
  Zev A. Wainberg, Adrian Anghel, Amrita J. Desai, Raul Ayala, Tong Luo, Brent Safran, Marlena S. Fejzo, J. Randolph Hecht, Dennis J. Slamon, Richard S. Finn> ;Clinical Cancer Research. 2010 Mar 1
• 996 citations
  PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
  Richard S. Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David Cohen, Amrita J. Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst, Gerret Los, Dennis...> ;Breast Cancer Research. 2009 Oct 29
• Join now to see all